- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Keloid in United Kingdom
Total 2385 results
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
Symphony Evolution, Inc.TerminatedAcute Myeloid Leukemia | AMLUnited States
-
Hamid SayarBayer; Merck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.Completed
-
Massachusetts General HospitalCelgene CorporationTerminatedAcute Myelogenous Leukemia | Acute Myeloid Leukemia (AML) | Acute Myelocytic Leukemia | Acute Granulocytic Leukemia | Acute Non-Lymphocytic LeukemiaUnited States
-
Maxim PharmaceuticalsCompletedLeukemiaUnited States, France, Israel, Australia, Canada, Sweden, Finland, Germany, New Zealand, Denmark, Estonia, United Kingdom
-
National Cancer Institute (NCI)CompletedUntreated Adult Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Childhood Acute Promyelocytic Leukemia (M3) | Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) | Untreated Childhood Acute Myeloid Leukemia and Other Myeloid MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes | Bone Marrow Diseases | Hematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Preleukemia | Chronic Myelomonocytic LeukemiaUnited States, France, Australia, Netherlands, Spain, Germany, United Kingdom, Finland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Donor | Hematopoietic Cell Transplant Recipient | HLA-A*0201 Positive Cells PresentUnited States
-
Suhu LiuRecruitingAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Granulocytic SarcomaUnited States
-
Boehringer IngelheimCompletedLeukemia, Myeloid, AcuteUnited States
-
CSL LimitedParexelCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); ImmunityBio... and other collaboratorsRecruitingAcute Myeloid LeukemiaUnited States
-
Medical College of WisconsinNot yet recruitingRelapsed Adult AML | Refractory AMLUnited States
-
M.D. Anderson Cancer CenterArray BioPharmaTerminated
-
Milton S. Hershey Medical CenterPfizerTerminatedAcute Myeloid LeukemiaUnited States
-
University of Kansas Medical CenterWithdrawn
-
CelgeneAbbVieCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
Polish Adult Leukemia GroupRecruiting
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
AmgenTerminatedAcute Myeloid LeukemiaUnited States, Australia, Germany
-
ImmunoGen, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingSecondary Acute Myeloid LeukemiaUnited States
-
Brian DrukerAbbVie; Oregon Health and Science University; Incyte CorporationActive, not recruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Sumithira VasuKiadis PharmaRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blasts 10 Percent or More of Bone Marrow Nucleated Cells | Allogeneic Stem Cell Transplant RecipientUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedChronic Phase Chronic Myeloid LeukemiaUnited States
-
AstraZenecaTerminatedAcute Myeloid LeukaemiaUnited States, Australia
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
UNC Lineberger Comprehensive Cancer CenterActive, not recruitingLeukemia, Myeloid, Acute | Minimal Residual DiseaseUnited States
-
Daiichi Sankyo, Inc.CompletedAMLUnited States, Korea, Republic of, Taiwan, United Kingdom, France, Australia, Spain, Italy, Canada, Singapore, Germany, Netherlands, Hong Kong, Belgium, Croatia, Czechia, Hungary, Poland, Serbia
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
ALX Oncology Inc.Active, not recruitingA Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)Acute Myeloid Leukemia | AML, AdultUnited States
-
Genentech, Inc.Completed
-
Pharmacyclics LLC.TerminatedAcute Myeloid Leukemia (AML)United States
-
Brian JonasNational Cancer Institute (NCI); AbbVieRecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid LeukemiaUnited States
-
Chroma TherapeuticsUnknownAcute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
Clavis PharmaSyneos Health; TheradexCompletedAcute Myeloid LeukemiaUnited States, Norway, Germany, France
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruiting
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia | Advanced Solid TumorsUnited States
-
Daiichi Sankyo, Inc.PlexxikonCompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterAscentage Pharma Group Inc.Not yet recruitingAdvanced Chronic Myeloid Leukemia | Philadelphia Chromosome-Positive Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia in Remission | Blasts Under 10 Percent of Bone Marrow Nucleated Cells | Therapy-Related Myeloid NeoplasmUnited States
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myeloproliferative Neoplasm | Acute Myeloid Leukemia With Gene MutationsUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Terminated
-
Cellectis S.A.RecruitingRelapsed/Refractory Acute Myeloid LeukemiaUnited States